Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases

Author:

Sugarman Olivia K.,Saloner Brendan,Richards Thomas M.,Lasser Elyse C.,Heath Teresa,Idries Shima,Weiner Jonathan P.,Bandara Sachini

Funder

Maryland Department of Health

Bloomberg Philanthropies

Publisher

Elsevier BV

Reference41 articles.

1. Coverage and prior authorization policies for medications for opioid use disorder in Medicaid managed care;Abraham;JAMA Health Forum,2022

2. Trends in use of medication to treat opioid use disorder during the COVID-19 pandemic in 10 state Medicaid programs;Austin;JAMA Health Forum,2023

3. Impact of administering buprenorphine to overdose survivors using emergency medical services;Carroll;Ann. Emerg. Med.,2023

4. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs;Caudarella;Drug Alcohol Depend.,2016

5. Centers for Disease Control and Prevention, & National Center for Health Statistics, 2022. Drug Overdose Mortality by State [Government]. National Center for Health Statistics. https://www.cdc.gov/nchs/pressroom/sosmap/drug_poisoning_mortality/drug_poisoning.htm.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3